Description Policymakers and public health experts unanimously recognise the disproportionate impacts of COVID-19 on vulnerable persons: even in countries with well-developed responses, the outbreak and its repercussions
 Viruses of the mind. Coping and joking about COVID-19. Bi-monthly report 7, January 2022. Result title Coping and joking about COVID-19. Bi-monthly report 7, January 2022.
 Periodic Reporting for period 1 - COVINFORM (COronavirus Vulnerabilities and INFOrmation dynamics Research and Modelling) Result description Policymakers and public health experts unanimously recognise the disproportionate impacts of COVID-19 on so-called vulnerable groups: even in countries with well-developed responses, the outbreak and its

Description The non-intended consequences of the epidemic control decisions to contain the COVID-19 pandemic are huge and affect the well-being of European citizens in terms of economics, social relationships and
 Predicting COVID-19 Vaccine Uptake Result title Predicting COVID-19 Vaccine Uptake
 Periodic Reporting for period 2 - SHARE-COVID19 (Non-intended health, economic and social effects of the COVID-19 epidemic control decisions: Lessons from SHARE (SHARE-COVID19)) Result description The non-intended consequences of the epidemic control decisions to contain the COVID-19 pandemic are huge and affect the well-being of European citizens in terms of economics, social relationships and

Description Despite of the successful advances achieved to date in the fight against the COVID-19 pandemic with the development of vaccines and therapy, the worldwide propagation of SARS-CoV-2 has resulted in the
 Humoral Responses Against Variants of Concern by COVID-19 mRNA Vaccines in Immunocompromised Patients Result title Humoral Responses Against Variants of Concern by COVID-19 mRNA Vaccines in Immunocompromised Patients
 CXCL12 and CXCL13 Cytokine Serum Levels Are Associated with the Magnitude and the Quality of SARS-CoV-2 Humoral Responses Result description the pre-formated search via the search engines listed on this page.Authors: DOIJournal title: VirusesJournal number: 14Journal publisher: MDPIPublished year: 2022DOI identifier: 10.3390/v14122665ISSN: 1999

Description The analysis of the clinical course and long-term follow-up of hospitalized COVID-19 patients to derive the role of different viral variants in the outcome of the infection, including post-acute sequelae
 COVID-19 data harmonisation and standardization SOPs Result title COVID-19 data harmonisation and standardization SOPs
 Efficacy of Licensed Monoclonal Antibodies and Antiviral Agents against the SARS-CoV-2 Omicron Sublineages BA.1 and BA.2 Result description Vicenti I.Journal title: VirusesJournal number: 2022 Jun 23;14(7):1374Journal publisher: Multidisciplinary Digital Publishing Institute (MDPI)Published year: 2022DOI identifier: 10.3390/v14071374ISSN: 1999

Description -19 patients, including VOC carriers.
 Periodic Reporting for period 1 - EPIC-CROWN-2 (Equine Polyclonal antibodies Immunotherapy against COVID-19/SARS-CoV2–VOC) Result title Periodic Reporting for period 1 - EPIC-CROWN-2 (Equine Polyclonal antibodies Immunotherapy against COVID-19/SARS-CoV2–VOC)

Description The current global COVID-19 pandemic has caused severe health and socio-economic challenges.
 Periodic Reporting for period 2 - iMPact (Novel, orally available immune modulator MP1032 with anti-SARS-CoV-2 and anti-cytokine activity) Result description Early intervention in COVID-19 is crucial to prevent severe disease and mortality.To reduce the disease burden and alleviate strain on healthcare systems, it is...

Description To deploy BV™/Key™ at hospitals in Israel, Germany and Italy that are managing COVID-19 patients. 2.
 Peer-reviewed publication about applicability of MeMed BV™ for serum on Key™ to COVID-19 patient management Result title Peer-reviewed publication about applicability of MeMed BV™ for serum on Key™ to COVID-19 patient management

Description As we currently experience with the COVID-19 pandemic, bioagents can cause enormous societal and economic damage.
 Periodic Reporting for period 1 - ABwipe (COVID-19 pandemic: An innovative, safe and effective bio-decontamination technology for non-toxic removal of biological agents, including coronavirus) Result title Periodic Reporting for period 1 - ABwipe (COVID-19 pandemic: An innovative, safe and effective bio-decontamination technology for non-toxic removal of biological agents, including coronavirus)

Description Contentflow provides a complete livestreaming platform ranging from a single hub for Contentflow is already in the process of assisting in the critical situation with COVID-19.
 Periodic Reporting for period 1 - Contentflow (Video Livestreaming Has Never Been Easier And Can Help Us Stay Connected During COVID-19) Result title Periodic Reporting for period 1 - Contentflow (Video Livestreaming Has Never Been Easier And Can Help Us Stay Connected During COVID-19)

Description In epidemic-like situations such as COVID-19, SEPSIS is prevalent in >60% of the admitted patients and all non-survivors had SEPSIS.
 Periodic Reporting for period 2 - RAPID-SEP-AST (Rapid diagnostic for bacterial SEPSIS and AMR urgently needed for ICU patients in COVID-19-like epidemics) Result title Periodic Reporting for period 2 - RAPID-SEP-AST (Rapid diagnostic for bacterial SEPSIS and AMR urgently needed for ICU patients in COVID-19-like epidemics)

Description fight COVID-19.
 Periodic Reporting for period 2 - COVID-X (COVID eXponential Programme) Result title Periodic Reporting for period 2 - COVID-X (COVID eXponential Programme) Result description EU/EEA fully vaccinated 86.3% of their population, but COVID-19 continues to affect all EU countries and... Result comments COVID-X
 First Call of Startups/ SMEs documentation Result comments COVID-X Result acronym COVID-X-790909
 First Ethical and Legal monitoring report Result comments COVID-X
 First Report on interconnection of third parties, CI /CD and policies Result comments COVID-X
 Sandbox design & Datalake creation and ingestion Result comments COVID-X
 CovidInnovation Intermediary Report Result comments COVID-X
 Ethical and legal framework Result comments COVID-X
 First Sandbox implementation and services provision Result comments COVID-X
 Final Sandbox implementation and services provision Result comments COVID-X
 Recommendation to health authorities and systems Result comments COVID-X
 Outreach Material Result comments COVID-X
 Public report of COVIDx programme_batch1 Result comments COVID-X
 Final Report on interconnection of third parties, CI /CD and policies Result comments COVID-X
 CovidInnovation Final Report Result comments COVID-X
 Public report of COVIDx programme1_batch2 Result comments COVID-X

Description CORONADX will provide one “front line” and two “second line” diagnostic tools for COVID-19.
 Age-specific COVID-19 case-fatality rate: no evidence of changes over time‏ Result title Age-specific COVID-19 case-fatality rate: no evidence of changes over time‏
 SARS‐CoV‐2 RNA stability in dry swabs for longer storage and transport at different temperatures Result description search engines listed on this page.Authors: Alfaro‐Núñez A, et al.Journal title: Transboundary and emerging diseasesJournal number: 69.2Journal publisher: WileyPublished year: 2022Published pages: 189-194DOI

Description -19 epidemic.
 Periodic Reporting for period 3 - DECISION (A minituarized disposable molecular diagnostics platform for combatting coronavirus infections) Result description The aim of DECISION is to develop an easy-to-use, low-cost, disposable test for COVID-19 that can give reliable results, on the spot, within minutes.

Description Among the biggest challenges in the COVID-19 outbreak are the lack of triangulation of clinical, epidemiologic and immunological information for evidence- based response strategies.
 Interplay Between Risk Perception, Behavior, and COVID-19 Spread Result title Interplay Between Risk Perception, Behavior, and COVID-19 Spread
 Development of the reproduction number from coronavirus SARS-CoV-2 case data in Germany and implications for political measures Result description Binder, Michael Meyer-HermannJournal title: BMC MedicineJournal number: 19/1Journal publisher: BioMed CentralPublished year: 2021DOI identifier: 10.1186/s12916-020-01884-4ISSN: 1741-7015

Description Overview: As of Feb 12th, 2020, the death toll of the 2019-nCoV (COVID-19) epidemic has surpassed 1000, rapidly eclipsing the total mortality of SARS.
 Genetic evidence for the association between COVID-19 epidemic severity and timing of non-pharmaceutical interventions Result title Genetic evidence for the association between COVID-19 epidemic severity and timing of non-pharmaceutical interventions

Description Protecting healthcare staff and preserving key clinical practice is a key WHO priority area for the immediate term in the COVID-19 pandemic, and also after peak crisis in the new practice landscape with
 Periodic Reporting for period 2 - PORSAV (Controlling viral aerosols in COVID-19 and beyond) Result title Periodic Reporting for period 2 - PORSAV (Controlling viral aerosols in COVID-19 and beyond) Result description Aerosols and droplets from COVID patients represent an important risk to surgical teams in the operating room (OR), who can be infected by patient breath or coughing (e.g. during endoscopy) or by leaks

Description 4th) with 1084 patients enrolled (567 with COVID-19).
 Respiratory support in patients with severe COVID-19 in the International Severe Acute Respiratory and Emerging Infection (ISARIC) COVID-19 study: a prospective, multinational, observational study Result title Respiratory support in patients with severe COVID-19 in the International Severe Acute Respiratory and Emerging Infection (ISARIC) COVID-19 study: a prospective, multinational, observational study

Description CPS4TIC was used successfully in the first wave of Covid-19 to ensure efficient and effective diagnosis and treatment of Covid-19 patients, while reducing the risk of infection drastically.
 Periodic Reporting for period 1 - ICU4Covid (Cyber-Physical Intensive Care Medical System for Covid-19) Result title Periodic Reporting for period 1 - ICU4Covid (Cyber-Physical Intensive Care Medical System for Covid-19) Result description ICU4Covid provides the Cyber-Physical System for Telemedicine and Intensive Care (CPS4TIC) ecosystem for Telehealth Europe. Result comments ICU4Covid
 Open Call Results Result comments ICU4Covid Result acronym ICU4Covid-853812
 Open Call Launch Result comments ICU4Covid
 Data Management Plan Result comments ICU4Covid
 Master Template to Establish ICU Hubs v1 Result comments ICU4Covid
 Communication Toolkit v2 Result comments ICU4Covid
 Common Clinical Operations Result comments ICU4Covid
 Audio-visual Material v1 Result comments ICU4Covid
 Communication Toolkit v1 Result comments ICU4Covid
 Project Website Result comments ICU4Covid
 Communication Action Plan Result comments ICU4Covid
 SSH Framework for Co-creating ICU Hubs Result comments ICU4Covid
 Explainable Artificial Intelligence for Improved Modeling of Processes Result comments ICU4Covid
 Master Template to Establish ICU Hubs v5 Result comments ICU4Covid
 Analysis of Data Normalization in Decision Making Process for ICU's Patients During the Pandemic Result comments ICU4Covid
 Analyzing Medical Data with Process Mining: A COVID-19 Case Study Result comments ICU4Covid
 Common Technical Requirements Result comments ICU4Covid
 Technical Handbook for the CPS4TIC Result comments ICU4Covid
 Legal and Ethical Framework Report v2 Result comments ICU4Covid
 Audio-visual Material v2 Result comments ICU4Covid
 Plan to Roll-Out Master Template in Europe Result comments ICU4Covid
 Novel transfer learning schemes based on Siamese networks and synthetic data Result comments ICU4Covid
 A Web-Based Tool for Comparative Process Mining Result comments ICU4Covid
 Master Template to Establish ICU Hubs v4 Result comments ICU4Covid
 Novel transfer learning schemes based on Siamese networks and synthetic data Result comments ICU4Covid
 Master Template to Establish ICU Hubs v2 Result comments ICU4Covid
 Master Template to Establish ICU Hubs v3 Result comments ICU4Covid
 Testing Methodology and Strategy Result comments ICU4Covid
 Explainable Artificial Intelligence for Improved Modeling of Processes Result comments ICU4Covid
 Design the Co-Creation Process Result comments ICU4Covid
 Handbook for Co-Creating an ICU Hub Result comments ICU4Covid
 Legal and Ethical Framework Report v1 Result comments ICU4Covid

Description As of 30th March 2020, the COVID-19 outbreak had caused over 735,000 infections globally, claiming more than 35,000 lives.
 Periodic Reporting for period 1 - RAPID-COVID (Robust Automation and Point of Care IDentification of COVID) Result title Periodic Reporting for period 1 - RAPID-COVID (Robust Automation and Point of Care IDentification of COVID) Result description and at different stages of the COVID-19 pandemic. Result comments RAPID-COVID Result acronym RAPID-COVID-788017
 Data Management Plan Result comments RAPID-COVID
 Elaborated plan for dissemination and exploitation of results Result comments RAPID-COVID
 Midterm Data Management Plan Result comments RAPID-COVID
 Areas of collaboration Result comments RAPID-COVID
 Project Communication Result comments RAPID-COVID
 White paper Result comments RAPID-COVID
 Health economics publication Result comments RAPID-COVID
 Health economics model with user input functionality Result comments RAPID-COVID
 Final Data Management Plan Result comments RAPID-COVID

Description The aim of the CleanAir project is to develop this technology to a market-ready and CE mark certified device for series production for protecting health practitioners and their patients against COVID-19
 Periodic Reporting for period 1 - CleanAir (Lab to Fab development of air decontamination system for protecting health practitioners against COVID19) Result description The persistence of the COVID-19 pandemic has shown that, due to numerous mutations of the virus, indoor air disinfection still plays a major role in combating the pandemic.

Description This project focuses on rapid (40min), simple, Point-of-Need COVID-19 testing, e.g. surgery/home (via first responders)/transit points of entry.
 16S rRNA gene sequencing of rectal swab in patients affected by COVID-19 Result title 16S rRNA gene sequencing of rectal swab in patients affected by COVID-19

Description The overall objective of this 5-year project is to build a multinational, adaptive European COVID-19 and emerging infectious diseases trial network, based on existing initiatives, experience and expertise
 Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results Result title Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results

Description The retail world is going through a period of strong evolution, accelerated by the ongoing COVID-19 pandemic.
 Periodic Reporting for period 2 - MiMEX (Micro Market Experience) Result description MIMEX is developing the first financially-viable and complete solution for retailers to deploy cashierless and modular micro-markets that is compatible with COVID-19 personal welfare protocols (i.e. masks

Description It will build on existing efforts, such as the COVID-19 Data Platform and the Versatile emerging infectious disease observatory project (VEO), thereby maximising efficiency.

Description 19 pandemic.
 19n01, a broadly neutralizing antibody against omicron BA.1, BA.2, BA.4/5, and other SARS-CoV-2 variants of concern Result title 19n01, a broadly neutralizing antibody against omicron BA.1, BA.2, BA.4/5, and other SARS-CoV-2 variants of concern

Description -19 for ships/ports, passengers/crew vaccination, ventilation systems and expedition vessels’ medical operation needs.
 Foundation report for COVID-19 related preliminary results Result title Foundation report for COVID-19 related preliminary results

Description -19.

Description The main objective of RBDCOV project is to test the efficacy, tolerability, and safety of two new vaccines against different variants of COVID-19 (Wuhan and South African/UK) based on the outstanding data

Description The END-VOC consortium will support the European and global response to the COVID-19 pandemic and Variants of Concern (VOC) through well characterised cohorts and linked with existing European and international

Description -19 patient's immune system reacts too slowly, giving it more time to do its job and eliminate the virus.